1 2 3
News & Information
Quality of Life Outcomes Comparable Regardless of Treatment With HRT or CRT for Low-Risk Prostate Cancer Quality of Life Outcomes Comparable Regardless of Treatment With HRT or CRT for Low-Risk Prostate Cancer

Hypofractionated radiotherapy is noninferior to conventional radiotherapy for quality-of-life outcomes among men with low-risk prostate tumors....

Are fighter pilots at greater risk for prostate cancer? The Air Force is now asking Are fighter pilots at greater risk for prostate cancer? The Air Force is now asking

The Air Force has begun to look at whether there's increased risk for prostate cancer among its fighter pilots. A new investigation by McClatchy shows just how serious the problem may be.
August 14th Webcast: Prostate Cancer and the Impact on Bone Health

Guest Speaker: Keith Crawford, MD, PhD
Director of Clinical Trials and Patient Education

FDA approves Bayer’s Nubeqa®, a new treatment for men with non-metastatic castration-resistant prostate cancer

Nubeqa was approved under the FDA’s Priority Review designation; approval granted three months ahead of target FDA action date.

Jesse's Story

Jesse Penn's story highlights the importance of prostate cancer survivors knowing about their bone health.
Clinical Trials: Another Treatment Option for Patients - Thomas Farrington Interview with URO Today Clinical Trials: Another Treatment Option for Patients - Thomas Farrington Interview with URO Today

PHEN President Tom Farrington talks to Dr. Alicia Morgans, Assoc. Professor of Medicine at the Northwestern University Feinberg School of Medicine on how to engage best with patients.  
Partners